Caxton Associates LP Anika Therapeutics, Inc. Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $35,626 - $40,865	-1,416 Reduced 15.47%	7,737 $201,000
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $317,604 - $393,481	-12,258 Reduced 57.25%	9,153 $262,000
Q4 2022 Feb 14, 2023	SELL	$23.85 - $31.91 $534,073 - $714,560	-22,393 Reduced 51.12%	21,411 $633,000
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $359,514 - $408,133	16,537 Added 60.65%	43,804 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $556,246 - $696,126	27,267 New	27,267 $609,000

123

11.5M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.